{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T15:11:32Z","timestamp":1777821092768,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Spanish Lung Cancer Group"},{"name":"Spanish Health Ministry approval","award":["GEC-MES-2014-01"],"award-info":[{"award-number":["GEC-MES-2014-01"]}]},{"name":"Carlos III National Health Institute"},{"name":"FEDER funds \u2013 a way to build Europe","award":["PI14\/01109"],"award-info":[{"award-number":["PI14\/01109"]}]},{"name":"FEDER funds \u2013 a way to build Europe","award":["PI18\/00920"],"award-info":[{"award-number":["PI18\/00920"]}]},{"name":"Department of Health of the Generalitat de Catalunya"},{"name":"CERCA Program \/ Generalitat de Catalunya"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lungcan.2020.06.034","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T11:48:23Z","timestamp":1593776903000},"page":"83-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group"],"prefix":"10.1016","volume":"147","author":[{"given":"J.","family":"Remon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"D\u00f3mine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ruffinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cilleruelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Garc\u00eda-Campelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Gonz\u00e1lez-Larriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Provencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Olmedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cumplido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Barenys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Majem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Massutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rodriguez-Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Martinez-Kareaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lianes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Reguart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2020.06.034_bib0005","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1470-2045(17)30445-X","article-title":"Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study","volume":"18","author":"Gatta","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0010","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1016\/S1470-2045(16)30123-1","article-title":"Novel therapeutic targets on the horizon for lung cancer","volume":"17","author":"Tan","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-642-10862-4_2","article-title":"Epidemiology of mesothelioma and historical background","volume":"189","author":"Craighead","year":"2011","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1289\/ehp.1002845","article-title":"Global magnitude of reported and unreported mesothelioma","volume":"119","author":"Park","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0025","first-page":"791","article-title":"Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends","volume":"14","author":"Montanaro","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-publhealth-031811-124704","article-title":"The worldwide pandemic of asbestos-related diseases","volume":"34","author":"Stayner","year":"2013","journal-title":"Annu. Rev. Public Health"},{"issue":"716\u2013724","key":"10.1016\/j.lungcan.2020.06.034_bib0035","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jamaoncol.2019.0446","article-title":"High time for complete ban on asbestos use in developing countries","volume":"5","author":"Chen","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/1471-2407-13-528","article-title":"Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020","volume":"13","author":"L\u00f3pez-Abente","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/oem.2007.034769","article-title":"Mesothelioma mortality in men: trends during 1977-2001 and projections for 2002-2016 in Spain","volume":"65","author":"Pitarque","year":"2008","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0055","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ejca.2015.07.033","article-title":"Survival patterns in lung and pleural cancer in Europe 1999-2007: results from the EUROCARE-5 study","volume":"51","author":"Francisci","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lungcan.2015.05.014","article-title":"Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England","volume":"89","author":"Damhuis","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0065","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group","volume":"108","author":"Rusch","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0070","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/09031936.00000811","article-title":"Predicting survival in malignant mesothelioma","volume":"38","author":"Musk","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0075","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","article-title":"Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales","volume":"88","author":"Beckett","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.23874","article-title":"Survival of pleural malignant mesothelioma in Italy: a population-based study","volume":"124","author":"Montanaro","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0090","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.12688\/f1000research.15512.2","article-title":"Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort","volume":"7","author":"Amin","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0095","doi-asserted-by":"crossref","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0100","first-page":"438","article-title":"Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database","volume":"1","author":"Rusch","year":"2012","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0105","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1200\/JCO.2012.47.1102","article-title":"PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer","volume":"31","author":"Paz-Ares","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0110","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.8517","article-title":"Randomized phase 2 study of maintenance pemetrexed (Pem) versus observation (Obs) for patients (pts) with malignant pleural mesothelioma (MPM) without progression after first-line chemotherapy: Cancer and Leukemia Group B (CALGB) 30901 (Alliance)","volume":"37","author":"Dudek","year":"2019","journal-title":"JCO"},{"key":"10.1016\/j.lungcan.2020.06.034_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz394.092","article-title":"Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: a multicenter open label phase II trial (NVALT19)","volume":"30","author":"Burgers","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2020.06.034_bib0120","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.18.01678","article-title":"Prophylactic irradiation of tracts in patients with malignant pleural mesothelioma: an open-label, multicenter, phase III randomized trial","volume":"37","author":"Bayman","year":"2019","journal-title":"J. Clin. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220305080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220305080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:42:43Z","timestamp":1759236163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500220305080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":24,"alternative-id":["S0169500220305080"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.06.034","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}